Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients

New Microbiol. 2019 Oct;42(4):221-224. Epub 2019 Oct 14.

Abstract

This short communication reports the preliminary results of Fecal Microbial Transplantation (FMT) impact on microbiota, microbial translocation (MT), and immune activation in four recurrent Clostridium difficile infection (R-CDI) patients. After FMT a restore of gut microbiota composition with a significant increase of fecal acetyl-putrescine and spermidine and fecal acetate and butyrate, a decrease of immune activation of T cells CD4+ and CD8+levels, and of LPS binding protein (LBP) level, were observed. Preliminary results indicate that FMT seems to be helpful not only as a CDI radical cure, with an impact on fecal microbiota and metabolome profiles, but also on MT and immune activation.

Keywords: Fecal microbiota transplantation; Microbial translocation; Recurrent Clostridium Difficile infection; T-Cell activation; gut microbiota; metabolome.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Clostridioides difficile*
  • Clostridium Infections* / immunology
  • Clostridium Infections* / microbiology
  • Clostridium Infections* / therapy
  • Fecal Microbiota Transplantation*
  • Feces / microbiology
  • Female
  • Gastrointestinal Microbiome*
  • Humans
  • Male
  • Metabolome*
  • Middle Aged
  • Recurrence
  • T-Lymphocytes* / immunology
  • Treatment Outcome